IE
TMBR

Israel Englander’s Timber Pharmaceuticals, Inc. TMBR Stock Holding History

Israel Englander’s Portfolio TMBR Stock Details TMBR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-2
Closed -$3K – 4439
2018
Q4 		$3K Sell
2
-27
-93% -$64K ﹤0.01% 3690
2018
Q3 		$83K Buy
29
+28
+2,800% +$80.9K ﹤0.01% 3756
2018
Q2 		$4K Buy
+1
New +$3.37K ﹤0.01% 3743
2018
Q1 		– Sell
-36
Closed -$59K – 4211
2017
Q4 		$59K Buy
+36
New +$98.1K ﹤0.01% 3711
2015
Q4 		– Sell
-2
Closed -$36K – 3873
2015
Q3 		$36K Buy
+2
New +$55.5K ﹤0.01% 3375

Other funds holding TMBR

VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
LTFS
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 27.61% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Israel Englander's TMBR Position: Q1 2019 in Review

Israel Englander sold out of Timber Pharmaceuticals, Inc. (TMBR) in Q1 2019, closing a stake of 2 shares — an estimated $3K sold.

Israel Englander first reported a position in TMBR in Q3 2015 and held it in 5 quarters. The position peaked at $83K in Q3 2018. 17 funds tracked by Wall St. Rank hold TMBR as of Q1 2019.

  • Israel Englander reported no remaining Timber Pharmaceuticals, Inc. position as of Q1 2019 after selling out during the quarter.
  • Israel Englander sold 2 Timber Pharmaceuticals, Inc. shares in Q1 2019, an estimated $3K.
  • Israel Englander first reported a position in Timber Pharmaceuticals, Inc. in Q3 2015 and held it in 5 quarters.
  • Israel Englander's Timber Pharmaceuticals, Inc. position peaked at $83K in Q3 2018.
  • 17 funds tracked by Wall St. Rank held Timber Pharmaceuticals, Inc. as of Q1 2019.

Based on Millennium Management's 13F filing for Q1 2019, filed 14 May 2019.